KORU MEDICAL SYSTEMS, INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
KORU MEDICAL SYSTEMS, INC. (KRMD) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$1.96 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-05
- KORU MEDICAL SYSTEMS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was -$2.40M.
- KORU MEDICAL SYSTEMS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $442.27K, a 722.02% increase year-over-year.
- KORU MEDICAL SYSTEMS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $194.65K, a 82.79% decline year-over-year.
- KORU MEDICAL SYSTEMS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $998.66K, a 54.06% increase year-over-year.
- KORU MEDICAL SYSTEMS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $904.65K, a 59.12% decline from fiscal 2024.
- KORU MEDICAL SYSTEMS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $2.21M.
- KORU MEDICAL SYSTEMS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$1.18M, a 753.87% decline from fiscal 2022.
- KORU MEDICAL SYSTEMS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $180.24K, a 81.52% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.96M 10-Q · filed 2026-08-05 | -$1.76M derived: sum of 3 quarters · filed 2026-08-05 | -$765.96K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $442.27K 10-Q · filed 2026-05-06 | $636.92K derived: sum of 2 quarters · filed 2026-05-06 | $1.64M derived: sum of 3 quarters · filed 2026-05-06 | $1.29M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $194.65K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.19M derived: sum of 2 quarters · filed 2026-03-12 | $850.84K derived: sum of 3 quarters · filed 2026-08-05 | $904.65K 10-K · filed 2026-03-12 |
| 2025-09-30 | $998.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $656.20K derived: sum of 2 quarters · filed 2026-08-05 | $710.00K 10-Q · filed 2025-11-12 | $1.84M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$342.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$288.66K 10-Q · filed 2026-08-05 | $842.56K derived: sum of 3 quarters · filed 2026-08-05 | $1.49M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $53.80K 10-Q · filed 2026-05-06 | $1.19M derived: sum of 2 quarters · filed 2026-05-06 | $1.83M derived: sum of 3 quarters · filed 2026-05-06 | $2.52M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.78M derived: sum of 2 quarters · filed 2026-03-12 | $2.46M derived: sum of 3 quarters · filed 2026-03-12 | $2.21M 10-K · filed 2026-03-12 |
| 2024-09-30 | $648.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.33M derived: sum of 2 quarters · filed 2025-11-12 | $1.08M 10-Q · filed 2025-11-12 | $1.33M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $685.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $433.30K 10-Q · filed 2025-08-06 | $686.19K derived: sum of 3 quarters · filed 2025-08-06 | $782.43K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$252.02K 10-Q · filed 2025-05-07 | $876.00 derived: sum of 2 quarters · filed 2025-05-07 | $97.11K derived: sum of 3 quarters · filed 2025-05-07 | -$132.33K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $252.90K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $349.13K derived: sum of 2 quarters · filed 2025-03-12 | $119.69K derived: sum of 3 quarters · filed 2025-03-12 | -$1.18M 10-K · filed 2025-03-12 |
| 2023-09-30 | $96.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$133.21K derived: sum of 2 quarters · filed 2024-11-13 | -$1.43M 10-Q · filed 2024-11-13 | -$1.11M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$229.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$1.53M 10-Q · filed 2024-08-07 | -$1.21M derived: sum of 3 quarters · filed 2024-08-07 | -$611.90K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$1.30M 10-Q · filed 2024-05-01 | -$977.01K derived: sum of 2 quarters · filed 2024-05-01 | -$382.46K derived: sum of 3 quarters · filed 2024-05-01 | -$579.99K derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $321.19K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $915.75K derived: sum of 2 quarters · filed 2024-03-13 | $718.22K derived: sum of 3 quarters · filed 2024-03-13 | $180.24K 10-K · filed 2024-03-13 |
| 2022-09-30 | $594.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $397.02K derived: sum of 2 quarters · filed 2023-11-08 | -$140.96K 10-Q · filed 2023-11-08 | $531.90K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$197.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$735.51K 10-Q · filed 2023-08-09 | -$62.65K derived: sum of 3 quarters · filed 2023-08-09 | $202.53K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$537.98K 10-Q · filed 2023-05-04 | $134.88K derived: sum of 2 quarters · filed 2023-05-04 | $400.06K derived: sum of 3 quarters · filed 2023-05-04 | $415.92K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $672.86K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $938.04K derived: sum of 2 quarters · filed 2023-03-08 | $953.90K derived: sum of 3 quarters · filed 2023-03-08 | $99.29K 10-K · filed 2023-03-08 |
| 2021-09-30 | $265.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $281.05K derived: sum of 2 quarters · filed 2022-11-09 | -$573.57K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $15.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$838.75K 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | -$854.61K 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $1.31M 10-K · filed 2022-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |